trending Market Intelligence /marketintelligence/en/news-insights/trending/VCIKTQXt2NMFacKEkGbyeg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Intra-Cellular Therapies offering underwriters exercise overallotment option

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Intra-Cellular Therapies offering underwriters exercise overallotment option

Intra-Cellular Therapies Inc. said underwriters of its public offering fully exercised their option to buy an additional 1,451,613 shares at $15.50 apiece.

Gross proceeds from the offering, including the overallotment option, were about $172 million, with net proceeds of about $162 million.

The closing of the sale of shares in relation to the overallotment option was completed Oct. 5.

J.P. Morgan Securities LLC and Leerink Partners LLC acted as joint book-running managers. Cantor Fitzgerald & Co. acted as lead manager and Canaccord Genuity Inc., BTIG LLC and Ladenburg Thalmann & Co. Inc. acted as co-managers for the offering.